SCHEMBL6550963

SCHEMBL6550963

N#Cc1ccccc1CNc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.49
▸ HPGD P15428 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ MAPT P10636 4/20 0.46
▸ P2RX7 Q99572 1/20 0.45
▸ CYP19A1 P11511 1/20 0.44
▸ HIF1A Q16665 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GAA P10253 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MAOA P21397 1/20 0.39
▸ MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6700006 0.89 P2RX7 (0.46) KDM4EHPGDTSHRHSD17B10MAPT
Trifluoroacetic Acid SCHEMBL6551836 0.86 HIF1A (0.43) KDM4EHPGDTSHRHSD17B10MAPT
SCHEMBL11567016 0.86 MAPT (0.46) KDM4EHPGDTSHRHSD17B10MAPT
SCHEMBL25796826 0.83 HPGD (0.50) KDM4EHPGDTSHRHSD17B10MAPT
SCHEMBL19921051 0.82 CYP19A1 (0.40) KDM4EHPGDTSHRHSD17B10MAPT
SCHEMBL25796823 0.82 ALDH1A1 (0.49) KDM4EHPGDTSHRHSD17B10MAPT
SCHEMBL28661673 0.82 BACE1 (0.51) KDM4EHSD17B10MAPTHIF1AALDH1A1
SCHEMBL20291630 0.80 L3MBTL1 (0.47) KDM4EHPGDTSHRHSD17B10MAPT
SCHEMBL10055008 0.79 MAPT (0.53) KDM4EHPGDMAPTHIF1AALDH1A1
SCHEMBL11593195 0.79 MAPT (0.61) HPGDMAPTP2RX7CYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1482929-A1 USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE Aventis Pharma Deutschland GmbH (DE) 2004-12-08 — — EP disclosed
WO-2003072098-A1 USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-09-04 — — WO disclosed
Send feedback